Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients

Japanese Journal of Infectious Diseases

Volumn 60, Issue 2-3, 2007, Pages 82-86

  Nazik, Hasan ^a   Öngen, Betigül ^a   Erturan, Zayre ^a   Şalcioǧlu, Melek ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFIED POLYMORPHIC DNA; STENOTROPHOMONAS MALTOPHILIA; THROAT CULTURE;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; STENOTROPHOMONAS MALTOPHILIA;

EID: 34347328051     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lyczak, J.-B., Cannon, C.-L. and Pier, G.-B. (2002): Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev., 15, 194-222.
2. Saiman, L. and Siegel, J. (2004): Infection control in cystic fibrosis. Clin. Microbiol. Rev., 17, 57-71.
3. Govan, J.-R. and Harris, G.-S. (1986): Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathoganesis. Microbiol. Sci., 3, 302-308.
4. Pier, G.-B. (2000): Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci., USA, 97, 8822-8828.
5. Krzewinski, J.-W., Nguyen, C.-D., Foster, J.-M., et al. (2001): Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Miorobiol., 39, 3597-3602.
6. Ballestero, S., Virseda, I., Escobar, H., et al. (1995): Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis., 14, 728-729.
7. Denton, M. (1997): Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol., 8, 15-19.
8. Denton, M., Todd, N.-J. and Littlewood, J.-M. (1996): Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Miorobiol. Infect. Dis., 15, 402-405.
9. Spilker, T., Coenye, T., Vandamme, P., et al. (2004): PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol., 42, 2074-2079.
10. Anthony, M., Rose, B., Pegler, M.-B., et al. (2002): Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol., 40, 2772-2778.
11. Clinical Laboratory Standards Institute (2005): Performance standard for antimicrobial susceptibility testing. Document M100-S14. Wayne, Pa.
12. Mammeri, H., Nazic, H., Naas, T., et al. (2004): AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother., 48, 4050-4053.
13. Williams, J.-G., Kubelik, A.-R., Livak, K.-J., et al. (1990): DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res., 18, 6531-6535.
14. Poirel, L., Guibert, M., Bellais, S., et al. (1999): Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. Antimicrob. Agents Chemother., 43, 1098-1104.
15. Saiman, L. (2004): Microbiology of early CF lung disease. Paediatr. Respir. Rev., 5 Suppl. A, S367-369.
16. Mahenthiralingam, E., Campbell, M.-E., Foster, J., et al. (1996): Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Mierobiol., 34, 1129-1135.
17. Mahenthiralingam, E., Campbell, M.-E. and Speert, D.-P. (1994): Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun., 62, 596-605.
18. International Pseudomonas aeruginosa Typing Study Group (1994): A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J. Infect. Dis., 169, 134-142.
19. Campbell, M., Mahenthiralingam, E. and Speert, D.-P. (2000): Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J. Clin. Microbiol., 38, 4614-4615.
20. Sener, B., Koseoglu, O., Ozcelik, U., et al. (2001): Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Int. J. Med. Microbiol., 291, 387-393.
21. Horrevorts, A.-M., Burst, J., Puyk, R.-J., et al. (1990): Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis. J. Med. Microbiol., 31, 119-124.
22. Hoogkamp-Korstanje, J.-A., Meis, J.-F., Kissing, J., et al. (1995): Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J. Clin. Microbiol., 33, 572-575.
23. Yagci, A., Ciragil, P., Over, U., et al. (2003): Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients. New Microbiol., 26, 109-114.
24. Valdezate, S., Vindel, A., Maiz, L., et al. (2001): Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg. Infect. Dis., 7, 113-122.
25. Manno, G., Cruciani, M., Romano, L., et al. (2005): Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Int. J. Antimicrob. Agents, 25, 193-197.
26. Koseoglu, O., Sener, B. and Gur, D. (2004): Molecular epidemiology of S. maltophilia strains isolated from pediatric patients. Mikrobiyol. Bull., 38, 9-19.